Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review
Considerable interest exists in the potential therapeutic value of dietary supplementation with the omega-3 fatty acids. Given the interplay between pro-inflammatory omega-6 fatty acids, and the less pro-inflammatory omega-3 fatty acids, it has been thought that the latter could play a key role in treating or preventing asthma. The purpose was to systematically review the scientific-medical literature in order to identify, appraise, and synthesize the evidence for possible treatment effects of omega-3 fatty acids in asthma.
Medline, Premedline, Embase, Cochrane Central Register of Controlled Trials, CAB Health, and, Dissertation Abstracts were searched to April 2003. We included randomized controlled trials (RCT's) of subjects of any age that used any foods or extracts containing omega-3 fatty acids as treatment or prevention for asthma. Data included all asthma related outcomes, potential covariates, characteristics of the study, design, population, intervention/exposure, comparators, and co interventions.
Ten RCT's were found pertinent to the present report.
Given the largely inconsistent picture within and across respiratory outcomes, it is impossible to determine whether or not omega-3 fatty acids are an efficacious adjuvant or monotherapy for children or adults. Based on this systematic review we recommend a large randomized controlled study of the effects of high-dose encapsulated omega-3 fatty acids on ventilatory and inflammatory measures of asthma controlling diet and other asthma risk factors. This review was limited because Meta-analysis was considered inappropriate due to missing data; poorly or heterogeneously defined populations, interventions, intervention-comparator combinations, and outcomes. In addition, small sample sizes made it impossible to meaningfully assess the impact on clinical outcomes of co-variables. Last, few significant effects were found.
- McKeever TM, Britton J: Diet and asthma. Am J Respir Crit Care Med 2004, 170:725–729. CrossRef
- Heart N, Institute LB, National Asthma Education and Prevention Program: Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. [http://www.nhlbi.nih.gov/health/prof/lung/asthma/practgde.htm] Bethesda, National Institutes of Health 1997., NIH No. 97–4051:
- Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 2002, 56:365–379. CrossRef
- Busse WW, Lemanske RFJ: Asthma. N Engl J Med 2001, 344:350–362. CrossRef
- National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics--2002 J Allergy Clin Immunol 2002, 110:S141-S219. CrossRef
- Horrobin DF: Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med Hypotheses 1987, 22:421–428. CrossRef
- Gil A: Polyunsaturated fatty acids and inflammatory diseases. Biomed Pharmacother 2002, 56:388–396. CrossRef
- Schachter HM, Reisman J, Tran K, Dales B, Kourad K, Barnes D, Sampson M, Morrison A, Gaboury I, Blackman J: Health Effects of Omega-3 Fatty Acids on Asthma. Rockville MD, AHRQ Publication No. 04-E013–2 2004., Technology Assessment 91:
- Woods RK, Thien FC, Abramson MJ: Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev 2002, CD001283.
- Jadad AR: Randomised controlled trials London, BMJ Publishing Group 1998.
- Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896–1900. CrossRef
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996, 17:1–12. CrossRef
- Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408–412. CrossRef
- Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52:377–384. CrossRef
- McDonald CV: Effect of fish-oil derived omega-3 fatty acid supplements on asthma control. Aust N Z J Med 1990, 20:526.
- Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K: Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J 2000, 16:861–865. CrossRef
- Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, Pang D, Armour C, Woolcock AJ: Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J 1998, 11:361–365. CrossRef
- Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH: Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988, 43:84–92. CrossRef
- Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, Harada S, Tanizaki Y: Effects of dietary supplementation with n-3 fatty acids compared with n-6 fatty acids on bronchial asthma. Intern Med 2000, 39:107–111. CrossRef
- Thien FC, Mencia-Huerta JM, Lee TH: Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis 1993, 147:1138–1143.
- Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H: Evening primose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 1989, 62:534–537.
- Kirsch CM, Payan DG, Wong MY, Dohlman JG, Blake VA, Petri MA, Offenberger J, Goetzl EJ, Gold WM: Effect of eicosapentaenoic acid in asthma. Clin Allergy 1988, 18:177–187. CrossRef
- Emelyanov AF: Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002, 20:596–600. CrossRef
- Dry J, Vincent D: Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991, 95:156–157. CrossRef
- Hodge L: Effect of fish oil supplements on severity of asthma in children. Annu Sci Meet Thorac Soc Aust N Z 1997.
- Payan DG, Wong MY, Chernov-Rogan T, Valone FH, Pickett WC, Blake VA, Gold WM, Goetzl EJ: Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid. J Clin Immunol 1986, 6:402–410. CrossRef
- Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH: The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989, 139:1395–1400.
- Mickleborough TD, Lindley MR, Ionescu AA, Fly AD: Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006, 129:39–49. CrossRef
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/6/26/prepub
- Treating asthma with omega-3 fatty acids: where is the evidence? A systematic review
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
BMC Complementary and Alternative Medicine
- Online Date
- July 2006
- Online ISSN
- BioMed Central
- Additional Links
- Author Affiliations
- 1. Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada
- 2. Chalmers Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
- 3. The Clinical Epidemiology Unit, Ottawa Health Research Institute, Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada
- 4. Canadian Coordinating Office for Health Technology Assessment, Ottawa, ON, Canada
- 5. Complementary Medicine Program, University of Maryland, Baltimore, MD, USA